Norman David Eansor

Insider Reports History

Entity
Individual
Location
8100 Southpark Way, A 8, Littleton, CO
Signature
/s/ Michael Loiacono, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Norman David Eansor:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIO-TECHNE Corp President-Protein Sciences Common Stock 2.12K $164K $77.42 Nov 16, 2021 Direct
BIO-TECHNE Corp President-Protein Sciences Restricted Stock Units 1.56K $125K $80.32 Nov 12, 2021 Direct
Marker Therapeutics, Inc. Director Common Stock 7.14K $3.46K $0.48 Mar 25, 2021 By the John R. Eansor 2020 Exempt Trust
Marker Therapeutics, Inc. Director Common Stock 7.14K $3.46K $0.48 Mar 25, 2021 By the Scott Eansor 2020 Exempt Trust
Marker Therapeutics, Inc. Director Common Stock 2.43K $1.18K $0.48 Mar 25, 2021 Direct
Marker Therapeutics, Inc. Director Stock Option (right to buy) 8K Jun 6, 2023 Direct
BIO-TECHNE Corp President-Protein Sciences Stock Options (Right to Buy) 0 Nov 16, 2021 Direct

Insider Reports Filed by Norman David Eansor

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRKR Marker Therapeutics, Inc. May 24, 2022 1 $0 4 May 26, 2022 Director
TECH BIO-TECHNE Corp Nov 12, 2021 14 -$10.2M 4 Nov 16, 2021 President-Protein Sciences
TECH BIO-TECHNE Corp Aug 31, 2021 1 -$774K 4 Sep 2, 2021 President-Protein Sciences
TECH BIO-TECHNE Corp Aug 6, 2021 6 -$481K 4 Aug 10, 2021 President-Protein Sciences
MRKR Marker Therapeutics, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
MRKR Marker Therapeutics, Inc. Mar 16, 2021 5 $250K 4 Jun 8, 2023 Director